Picture of Bruker logo

BRKR Bruker Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapFalling Star

Annual cashflow statement for Bruker, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line281299429114-8.3
Depreciation
Deferred Taxes
Non-Cash Items44.146-81.195.7171
Unusual Items
Other Non-Cash Items
Changes in Working Capital-126-144-87.8-78.2-145
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities282274350251134
Capital Expenditures-92-129-107-115-120
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-100-122-219-1,642-76.3
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-192-252-326-1,757-197
Financing Cash Flow Items-0.5-14.50.3-24.9-8.3
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities319-415-1931,230135
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash386-423-157-305117